Nemec Sarah

Senior VP, Finance and PAO

Nemec Sarah has filed 3 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Sep 21, 2026.

On the most recent filing, Nemec Sarah is listed as Senior VP, Finance and PAO at Bolt Biotherapeutics, Inc. Inside the rolling window, Nemec Sarah reported 3 open-market purchases totaling $3K in BOLT and 3 open-market sales totaling $26K in BOLT. The largest disclosed transaction in the window is a sale of 4,077 BOLT shares on Sep 18, 2026, worth $13K.

Companies traded

Other insiders at BOLT

Insider Buying

$3K

reported purchases (SEC code P)

Insider Selling

$26K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
BOLTPurchase$2KSep 21SEC ↗
BOLTSale$3KSep 21SEC ↗
BOLTSale$10KSep 21SEC ↗
BOLTSale$13KSep 21SEC ↗
BOLTPurchase$576Feb 4SEC ↗
BOLTPurchase$687Oct 24SEC ↗
Showing 1–6 of 6
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Nemec Sarah made?

Nemec Sarah has filed 3 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.

Which companies does Nemec Sarah trade?

Nemec Sarah has filed SEC Form 4 disclosures for 1 company, including BOLT.

When was Nemec Sarah's most recent SEC Form 4 filing?

Nemec Sarah's most recent SEC Form 4 filing on Tracefour is dated Sep 21, 2026.

What is Nemec Sarah's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Nemec Sarah is listed as Senior VP, Finance and PAO.

What is Nemec Sarah's total buy and sell value in the current window?

Inside the rolling retention window, Nemec Sarah bought $3K and sold $26K based on SEC Form 4 filings.

What was Nemec Sarah's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 4,077 BOLT shares on 2026-09-18, worth $13K, per SEC Form 4 filings.